Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

18.940
+0.7103.89%
Volume:2.39M
Turnover:45.31M
Market Cap:50.36B
PE:16.12
High:19.250
Open:18.460
Low:18.370
Close:18.230
52wk High:29.000
52wk Low:12.535
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.04
T/O Rate:0.44%
Dividend:0.35
Dividend Rate:1.85%
EPS(LYR):1.175
ROE:6.75%
ROA:1.32%
PB:0.93
PE(LYR):16.12
PS:1.12

Loading ...

Fosun Pharmaceutical's Serplulimab Injection Included in Chinese Drug Regulator's Breakthrough Therapy Drug Program; Shares Down 4%

MT Newswires Live
·
Nov 21, 2025

Fosun Pharma's HLX10 (Serplulimab) Included in Breakthrough Therapy Program for Gastric Cancer Treatment

Stock News
·
Nov 20, 2025

Analysis of Hong Kong Stock Connect Holdings as of November 19

Stock News
·
Nov 19, 2025

HKEX Announcement Highlights | XIAOMI-W Reports Record High Adjusted Net Profit of RMB11.311 Billion in Q3, Smartphone Shipments Grow YoY for 9 Consecutive Quarters

Stock News
·
Nov 18, 2025

Fosun Pharmaceutical Unit's Application to Register Electrolyte Powder Gets Accepted in China

MT Newswires Live
·
Nov 18, 2025

FOSUN PHARMA (600196.SH): Registration Application for Compound Polyethylene Glycol (3350) Electrolyte Powder Accepted

Stock News
·
Nov 18, 2025

FOSUN PHARMA's (600196.SH) Subsidiary Receives FDA Approval for Drug

Stock News
·
Nov 14, 2025

Fosun Pharma (02196) Proposes Executive Director Election, Schedules EGM in December

Bulletin Express
·
Nov 07, 2025

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details

Bulletin Express
·
Nov 07, 2025

Fosun Pharma Approves First Grants Under 2025 A Share Option, H Share RSU Schemes

MT Newswires Live
·
Nov 05, 2025

Shanghai Fosun Pharmaceutical (02196) and Fosun International Approve 2025 H Share RSU Scheme, First Grant Confirmed at 10,589,500 RSUs

Bulletin Express
·
Nov 04, 2025

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces First Grant of A Share Options Under 2025 Scheme

Bulletin Express
·
Nov 04, 2025

FOSUN PHARMA (02196) Grants 4.5351 Million A-Share Options in Total

Stock News
·
Nov 04, 2025

Fosun Pharma (02196, 600196) Announces Unchanged Share Capital and Treasury Shares for October 2025

Bulletin Express
·
Nov 04, 2025

Fosun Pharma Releases Q3 2025 Report: Innovation Deliveries Continue, Novel Drug Revenue Exceeds RMB 6.7 Billion in First Three Quarters

Deep News
·
Nov 03, 2025

Fosun Pharma Plans to Spin Off Vaccine Subsidiary for Hong Kong IPO

Deep News
·
Oct 31, 2025

Stock Track | FOSUN PHARMA Soars 5.11% on Strong Q1-Q3 Results and Advancing Product Pipeline

Stock Track
·
Oct 31, 2025

FOSUN PHARMA (02196) Rises Nearly 4% Intraday as Q1-Q3 Net Profit Grows 25.5% YoY, Continues Advancing Innovative Product Launches

Stock News
·
Oct 31, 2025

Breaking Boundaries with AI: FANGZHOU JIANKE (06086) and FOSUN PHARMA (02196) Forge Strategic Partnership to Build a Digital Ecosystem for Psoriasis Management

Stock News
·
Oct 29, 2025

Guoyi Securities Maintains "Buy" Rating on Fosun Pharma (02196) with Target Price of HK$26.5

Stock News
·
Oct 29, 2025